Role of immunohistochemical detection of lymph-node metastases in management of breast cancer

R. J. Cote(USC Norris Comprehensive Cancer Center), H Fpeterson(Dana-Farber Cancer Institute), Benjaporn Chaiwun, RD Gelber(Dana-Farber Cancer Institute), Aron Goldhirsch(European Institute of Oncology), Monica Castiglione‐Gertsch(International Breast Cancer Study Group), B.A. Gusterson(Breast Cancer Now), AM Neville(Ludwig Cancer Research)
The Lancet
September 1, 1999
10.1016/s0140-6736(98)11104-2
Cited by 506

Abstract

Related Papers

Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes
Umberto Veronesi, Giovanni Paganelli, Viviana Galimberti et al.|The Lancet|1997|1.9k
Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update
Bernard Fisher, Madeline Bauer, D. Lawrence Wickerham et al.|Cancer|1983|1k
Micrometastases and Survival in Stage II Colorectal Cancer
Gerrit‐Jan Liefers, Anne‐Marie Cleton-Jansen, Cornelis J.�H. van de Velde et al.|New England Journal of Medicine|1998|601
Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer.
A. J. Nixon, Donna Neuberg, Daniel F. Hayes et al.|Journal of Clinical Oncology|1994|580
Antigen Retrieval Immunohistochemistry: Past, Present, and Future
Shan-Rong Shi, Richard J. Côté, Clive R. Taylor|Journal of Histochemistry & Cytochemistry|1997|517